Integrated Filing — IndAS



General information about company
Scrip Code 500770
NSE Symbol TATACHEM
MSEI Symbol NOTLISTED
ISIN INE092A01019
Name of company Tata Chemicals Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 25-Jul-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 18-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 25-Jul-2025   13:30:00
End date and time of board meeting 25-Jul-2025   17:15:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 37190000000
Other income 960000000
Total income 38150000000
2 Expenses
(a) Cost of materials consumed 8270000000
(b) Purchases of stock-in-trade 1480000000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -2420000000
(d) Employee benefit expense 5170000000
(e) Finance costs 1470000000
(f) Depreciation, depletion and amortisation expense 2800000000
(f) Other Expenses
1 Power and fuel 4530000000 4530000000
2 Freight and forwarding charges 7040000000 7040000000
3 Other expenses 6630000000 6630000000
Total other expenses 18200000000
Total expenses 34970000000
3 Total profit before exceptional items and tax 3180000000
4 Exceptional items 0
5 Total profit before tax 3180000000
6 Tax expense
7 Current tax 780000000
8 Deferred tax -340000000
9 Total tax expenses 440000000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 2740000000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 420000000
16 Total profit (loss) for period 3160000000
17 Other comprehensive income net of taxes 7210000000
18 Total Comprehensive Income for the period 10370000000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 2520000000
Total profit or loss, attributable to non-controlling interests 640000000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 9740000000
Total comprehensive income for the period attributable to owners of parent non-controlling interests 630000000
21 Details of equity share capital
Paid-up equity share capital 2550000000
Face value of equity share capital 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 9.89
Diluted earnings (loss) per share from continuing operations 9.89
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 9.89
Diluted earnings (loss) per share from continuing and discontinued operations 9.89
24 Debt equity ratio 0.0031
25 Debt service coverage ratio 0.0388
26 Interest service coverage ratio 0.0441
27 Disclosure of notes on financial results



Remarks
Debt equity ratio 0.31 times
Debt service coverage ratio 3.88 times
Interest service coverage ratio 4.41 times


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Basic chemistry products 27220000000 27220000000
2 Specialty products 10010000000 10010000000
3 Unallocated 0 0
Total Segment Revenue 37230000000
Less: Inter segment revenue 40000000 40000000
Revenue from operations 37190000000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Basic chemistry products 3000000000 3000000000
2 Specialty products 1110000000 1110000000
3 Unallocated 0 0
Total Profit before tax 4110000000
i. Finance cost 1470000000 1470000000
ii. Other Unallocable Expenditure net off Unallocable income -540000000 -540000000
Profit before tax 3180000000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Basic chemistry products 236540000000 236540000000
2 Specialty products 32630000000 32630000000
3 Unallocated 0 0
Total Segment Asset 269170000000 269170000000
Un-allocable Assets 119260000000 119260000000
Net Segment Asset 388430000000 388430000000
4 Segment Liabilities
Segment Liabilities
1 Basic chemistry products 39370000000 39370000000
2 Specialty products 12050000000 12050000000
3 Unallocated 0 0
Total Segment Liabilities 51420000000 51420000000
Un-allocable Liabilities 104860000000 104860000000
Net Segment Liabilities 156280000000 156280000000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Change in fair value of equity investments carried at fair value through OCI 8800000000 8800000000
2 Remeasurement of defined employee benefit plans -100000000 -100000000
3 Share of other comprehensive credit /(charge) of joint ventures (net of tax) 120000000 120000000
Total Amount of items that will not be reclassified to profit and loss 8820000000
2 Income tax relating to items that will not be reclassified to profit or loss 1260000000
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of cash flow hedges -140000000 -140000000
2 Changes in foreign currency translation reserve -220000000 -220000000
3 Share of other comprehensive (charge) / credit of joint ventures (net of tax) 0 0
Total Amount of items that will be reclassified to profit and loss -360000000
4 Income tax relating to items that will be reclassified to profit or loss -10000000
5 Total Other comprehensive income 7210000000